We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

10 hedge funds and large institutions have $557K invested in Yield10 Bioscience, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

25% more funds holding

Funds holding: 8 → 10 (+2)

65% less capital invested

Capital invested by funds: $1.61M → $557K (-$1.05M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$23K
2
VKH
Virtu KCG Holdings
New York
+$23K
3
Citadel Advisors
Citadel Advisors
Florida
+$11.5K
4
UBS Group
UBS Group
Switzerland
+$3.84K

Top Sellers

Rank Fund Capital Flow
1
CC
Cannell & Co
New York
-$347K
2
FA
FCG Advisors
New Jersey
-$26.9K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$26.9K
4
GC
GMT Capital
Georgia
-$7.68K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Birchview Capital
Vermont
$301K – – –
GC
2
GMT Capital
Georgia
$110K -$7.68K -2 -6%
BIT
3
BlackRock Institutional Trust
California
$55K – – –
Goldman Sachs
4
Goldman Sachs
New York
$21K +$23K +6 New
VKH
5
Virtu KCG Holdings
New York
$21K +$23K +6 New
FA
6
FCG Advisors
New Jersey
$15K -$26.9K -7 -58%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$12K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$11K +$11.5K +3 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$4K -$26.9K -7 -88%
UBS Group
10
UBS Group
Switzerland
$3K +$3.84K +1 New
BA
11
BlackRock Advisors
Delaware
$1K – – –
BFA
12
BlackRock Fund Advisors
California
$1K – – –
Group One Trading
13
Group One Trading
Illinois
$1K – – –
Morgan Stanley
14
Morgan Stanley
New York
$1K – – –
WEC
15
Winslow Evans & Crocker
Massachusetts
$12 – – –
CC
16
Cannell & Co
New York
– -$347K -80 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$6K -1 Closed
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K – –
PSC
19
Prentiss Smith & Co
Vermont
– -$1K – –

YTEN Hedge Fund Activity: Q4 2016 in Review

10 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2016, worth a combined $557K — down 65% from $1.61M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new YTEN positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $23K. The largest seller was Cannell & Co, exiting entirely with an estimated $347K sold.

  • 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2016, up from 8 in Q3 2016.
  • Funds reported $557K of Yield10 Bioscience, Inc. Common Stock stock for Q4 2016, down 65% quarter-over-quarter.
  • 4 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2016 and 2 closed out, a net change of +2 holders.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2016 was Goldman Sachs, an estimated $23K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2016 was Cannell & Co, an estimated $347K sold.

Based on aggregated 13F filings for Q4 2016.